Recruiting Pulmonary Hypertension Studies in Fayetteville
About Pulmonary Hypertension Clinical Trials in Fayetteville
Pulmonary hypertension is a type of high blood pressure that affects the arteries in the lungs and the right side of the heart. It can lead to heart failure if untreated. Treatment includes vasodilators, endothelin receptor antagonists, and PDE-5 inhibitors.
There are currently 3 pulmonary hypertension clinical trials recruiting participants in Fayetteville, NC. These studies are seeking a combined 2,996 participants. Research is being sponsored by Stratpharma AG, National Cancer Institute (NCI), SWOG Cancer Research Network. Clinical trial participation is free and participants receive study-related medical care at no cost.
Pulmonary Hypertension Clinical Trials in Fayetteville — FAQ
Are there pulmonary hypertension clinical trials in Fayetteville?
Yes, there are 3 pulmonary hypertension clinical trials currently recruiting in Fayetteville, NC. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Fayetteville?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Fayetteville research site will contact you about next steps.
Are clinical trials in Fayetteville free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Fayetteville studies also compensate for your time and travel.
What pulmonary hypertension treatments are being tested?
The 3 active trials in Fayetteville are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary hypertension.
Data updated July 13, 2026 from ClinicalTrials.gov